创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

张雅晨, 孙建国. 小檗碱预防性治疗糖尿病肾病的研究进展[J]. 药学进展, 2023, 47(3): 217-226. DOI: 10.20053/j.issn1001-5094.2023.03.006
引用本文: 张雅晨, 孙建国. 小檗碱预防性治疗糖尿病肾病的研究进展[J]. 药学进展, 2023, 47(3): 217-226. DOI: 10.20053/j.issn1001-5094.2023.03.006
ZHANG Yachen, SUN Jianguo. Research Progress of Berberine in Prophylactic Treatment of Diabetic Nephropathy[J]. Progress in Pharmaceutical Sciences, 2023, 47(3): 217-226. DOI: 10.20053/j.issn1001-5094.2023.03.006
Citation: ZHANG Yachen, SUN Jianguo. Research Progress of Berberine in Prophylactic Treatment of Diabetic Nephropathy[J]. Progress in Pharmaceutical Sciences, 2023, 47(3): 217-226. DOI: 10.20053/j.issn1001-5094.2023.03.006

小檗碱预防性治疗糖尿病肾病的研究进展

Research Progress of Berberine in Prophylactic Treatment of Diabetic Nephropathy

  • 摘要: 糖尿病肾病是糖尿病微血管并发症之一,其发病机制复杂,与糖脂代谢紊乱、炎症、氧化应激、自噬受损、肠道菌群失调等因素交叉关联,也是导致终末期肾病的主要原因。综述了糖尿病肾病的主要发病机制以及小檗碱预防性治疗糖尿病肾病的研究进展,旨在为糖尿病肾病治疗药物的研发提供参考。

     

    Abstract: Diabetic nephropathy is one of the microvascular complications of diabetes mellitus. Its pathogenesis is complex and crosslinked with factors including glucolipid metabolism disorders, inflammation, oxidative stress, impaired autophagy, and intestinal flora imbalance. It is also the main cause of end-stage renal disease. This article has reviewed the main pathogenesis of diabetic nephropathy and the research progress of berberine in the prophylactic treatment of diabetic nephropathy, aiming to provide references for the development of drugs for the treatment of diabetic nephropathy.

     

/

返回文章
返回